Guidelines for the management of pemphigus vulgaris.
These guidelines for management of pemphigus vulgaris have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.
Harman
K E
KE
St John's Institute of Dermatology, St Thomas' Hospital, London, SE1 7EH UK. karenharman@doctors.org.uk
Albert
S
S
Black
M M
MM
D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010392:Pemphigus / Q000188:drug therapy / Q000628:therapy*; D017893:Photopheresis; D010951:Plasma Exchange
D003879:Dermatologic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents